Could ALDH2 * 2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?

Shaomin Yan; Guang Wu

doi:10.18632/oncotarget.23605

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Could ALDH2^*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?

Shaomin Yan and Guang Wu _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:12503-12512. https://doi.org/10.18632/oncotarget.23605

Metrics: PDF 1610 views | HTML 3094 views | ?

Abstract

Shaomin Yan1 and Guang Wu1

1Bioscience and Technology Research Center, Guangxi Academy of Sciences, Nanning, Guangxi, 530007, China

Correspondence to:

Guang Wu, email: [email protected]

Keywords: aldehyde dehydrogenase 2; ALDH2^*2; East Asian; stem cell; ovarian cancer

Received: July 03, 2017 Accepted: December 16, 2017 Published: December 22, 2017

ABSTRACT

It is curious that East Asian women have a low incidence and mortality of ovarian cancer in various epidemiological studies. Although different explanations were given, they appear unsubstantial. We notice that East Asian population usually are inactive aldehyde dehydrogenase 2 mutation (ALDH2^*2) carriers, and ALDH plays an important role in the resistance of ovarian cancer to chemotherapeutics, especially in ovarian cancer stem cells. Therefore, we hypothesize whether ALDH2 mutation is the major reason for low incidence and mortality of ovarian cancer in East Asian women, and use the evidence from literature, transcriptomic data with average 5-year overall survival to confirm our hypothesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23605

Publication Alerts

Reviews:

Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?

Abstract

Could ALDH2^*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?